- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $14.23M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.15M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $12.61M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $11.3M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.18M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $14.91M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.61M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.91M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.31M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 209.2K sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$5.32M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$4.94M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $123K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$24.81 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$24.81 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.43M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$5.19M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$5.23M |